Prioritization Rationale
The priority intervention is to administer inotropic agents to improve cardiac contractility. In cardiogenic shock following myocardial infarction, the fundamental defect is impaired myocardial contractility . The goal of therapy is to break the vicious cycle of low output, hypoperfusion, and worsening cardiac function. Inotropes such as dobutamine or milrinone directly enhance contractility, which will increase cardiac output, improve tissue perfusion, and secondarily allow the compensatory SVR to decrease as the sympathetic drive is reduced. This directly addresses the underlying pathophysiology of pump failure.
Analysis of Incorrect Options
Increasing intravenous fluid administration (Option 1) is contraindicated. The PCWP of 22 mmHg already indicates volume overload and pulmonary venous congestion. Administering more fluid would further increase the filling pressure without improving contractility, worsening pulmonary edema and respiratory failure. Vasopressor medications (Option 2), such as norepinephrine, would increase SVR and blood pressure but at the cost of increasing the workload of the already-failing left ventricle. While vasopressors may be necessary for refractory hypotension, they are not the first-line priority when the primary issue is contractile dysfunction and afterload is already elevated. Preparing for immediate cardioversion (Option 3) is not indicated as there is no evidence of a tachyarrhythmia in the presented data; the hemodynamic profile is consistent with sinus tachycardia as a compensatory mechanism, not a primary arrhythmic event.
Clinical Integration and Monitoring
Advanced hemodynamic monitoring, as provided by the pulmonary artery catheter, is a cornerstone of goal-directed therapy in cardiac surgery and critical care to differentiate shock states and guide management . In this case, it precisely identifies a cardiogenic rather than hypovolemic or distributive etiology. After initiating inotropic support, the nurse would monitor for an increase in CO, a decrease in SVR, and a gradual reduction in PCWP as forward flow improves. For patients with refractory shock despite pharmacological support, mechanical circulatory support devices like veno-arterial ECMO or an intra-aortic balloon pump (IABP) may be considered to unload the left ventricle and support systemic perfusion, though their impact on myocardial recovery remains an area of active investigation . The presence of a low cardiac output state in this context is a critical marker of disease severity, and its correction is the immediate clinical priority .
The classic profile includes elevated PCWP (>18 mmHg), low CO/CI, and elevated SVR. This patient's PCWP 22 mmHg confirms pulmonary congestion, not hypovolemia.
The priority is to enhance contractility with inotropes (e.g., dobutamine). This increases CO and breaks the compensatory vasoconstriction cycle, reducing SVR.
Avoid fluid boluses when PCWP is high; they worsen pulmonary edema. Vasopressors increase already high SVR, raising myocardial oxygen demand.
학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요.